NASDAQ: CLPT
ClearPoint Neuro, Inc.
Healthcare · Medical - Devices
After hours: $15.58(+0.19%) · as of 7:47 PM ET
Market Cap
$466.34M
52w High
$30.10
52w Low
$8.27
P/E
-13.18
Volume
467.53K
Outstanding Shares
29.99M
Valuation Data Insufficient
Every projected year produces negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 48.24% over the last year. Revenue grew 25.86% over the trailing twelve months. Operating margin moved from -67.33% to -73.42%. Free cash flow declined 167.09% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -73.42%. A decisive move in revenue — currently up 25.86% — would be the clearest signal to resolve the ambiguity.
Company profile
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States.
Valuation
Stock splits
Every 40 shares became 1
Profitability & growth
Analyst consensus
3
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est -$0.31 · Revenue est $12.3M
View